These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10521012)

  • 1. No effect of adjunctive fluoxetine on eating behavior or weight phobia during the inpatient treatment of anorexia nervosa: an historical case-control study.
    Strober M; Pataki C; Freeman R; DeAntonio M
    J Child Adolesc Psychopharmacol; 1999; 9(3):195-201. PubMed ID: 10521012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does adjunctive fluoxetine influence the post-hospital course of restrictor-type anorexia nervosa? A 24-month prospective, longitudinal followup and comparison with historical controls.
    Strober M; Freeman R; DeAntonio M; Lampert C; Diamond J
    Psychopharmacol Bull; 1997; 33(3):425-31. PubMed ID: 9550888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does fluoxetine augment the inpatient treatment of anorexia nervosa?
    Attia E; Haiman C; Walsh BT; Flater SR
    Am J Psychiatry; 1998 Apr; 155(4):548-51. PubMed ID: 9546003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.
    Walsh BT; Kaplan AS; Attia E; Olmsted M; Parides M; Carter JC; Pike KM; Devlin MJ; Woodside B; Roberto CA; Rockert W
    JAMA; 2006 Jun; 295(22):2605-12. PubMed ID: 16772623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.
    Duvvuri V; Cromley T; Klabunde M; Boutelle K; Kaye WH
    Int J Eat Disord; 2012 Mar; 45(2):294-7. PubMed ID: 21344468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of selective serotonin reuptake inhibitors in eating disorders.
    Mayer LE; Walsh BT
    J Clin Psychiatry; 1998; 59 Suppl 15():28-34. PubMed ID: 9786308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of fluoxetine in anorexia nervosa before and after weight restoration.
    Sebaaly JC; Cox S; Hughes CM; Kennedy ML; Garris SS
    Ann Pharmacother; 2013 Sep; 47(9):1201-5. PubMed ID: 24259736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.
    Kaye WH; Nagata T; Weltzin TE; Hsu LK; Sokol MS; McConaha C; Plotnicov KH; Weise J; Deep D
    Biol Psychiatry; 2001 Apr; 49(7):644-52. PubMed ID: 11297722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based treatment of anorexia nervosa.
    Fairburn CG
    Int J Eat Disord; 2005; 37 Suppl():S26-30; discussion S41-2. PubMed ID: 15852315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine and eating disorders.
    Morgan JF
    Hosp Med; 1999 Sep; 60(9):686. PubMed ID: 10621803
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoxetine for treatment of anorexia nervosa.
    Dettling M; Opgen-Rhein C; Quante A; Anghelescu I
    JAMA; 2006 Nov; 296(20):2439-40; author reply 2440. PubMed ID: 17119138
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine treatment of anorexia nervosa: important but disappointing results.
    Crow SJ
    JAMA; 2006 Jun; 295(22):2659-60. PubMed ID: 16772631
    [No Abstract]   [Full Text] [Related]  

  • 13. Obsessive-compulsive disorder, trichotillomania, and anorexia nervosa: a case report.
    Pryor TL; Martin RL; Roach N
    Int J Eat Disord; 1995 Dec; 18(4):375-9. PubMed ID: 8580925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors in anorexia nervosa.
    Bergh C; Eriksson M; Lindberg G; Södersten P
    Lancet; 1997 Oct; 350(9083):1033-4. PubMed ID: 9329540
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.
    Barbarich NC; McConaha CW; Halmi KA; Gendall K; Sunday SR; Gaskill J; La Via M; Frank GK; Brooks S; Plotnicov KH; Kaye WH
    Int J Eat Disord; 2004 Jan; 35(1):10-5. PubMed ID: 14705152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open trial of fluoxetine in patients with anorexia nervosa.
    Kaye WH; Weltzin TE; Hsu LK; Bulik CM
    J Clin Psychiatry; 1991 Nov; 52(11):464-71. PubMed ID: 1744064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine use in adolescent anorexia nervosa.
    Dennis K; Le Grange D; Bremer J
    Eat Weight Disord; 2006 Jun; 11(2):e53-6. PubMed ID: 16809970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1-year follow-up of a multi-center treatment trial of adults with anorexia nervosa.
    Yu J; Stewart Agras W; Halmi KA; Crow S; Mitchell J; Bryson SW
    Eat Weight Disord; 2011 Sep; 16(3):e177-81. PubMed ID: 22290033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs.
    Halmi KA; Agras WS; Crow S; Mitchell J; Wilson GT; Bryson SW; Kraemer HC
    Arch Gen Psychiatry; 2005 Jul; 62(7):776-81. PubMed ID: 15997019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does percent body fat predict outcome in anorexia nervosa?
    Mayer LE; Roberto CA; Glasofer DR; Etu SF; Gallagher D; Wang J; Heymsfield SB; Pierson RN; Attia E; Devlin MJ; Walsh BT
    Am J Psychiatry; 2007 Jun; 164(6):970-2. PubMed ID: 17541059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.